Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants
ConclusionAlmost allCHEK2-associated BCs were ER + IDC-NST, with most classified as luminal B with or without HER2 overexpression. NGS supported the luminal-like phenotype and confirmedCHEK2 as an oncogenic driver in the majority of cases. Responses to neoadjuvant chemotherapy were variable but mostly incomplete.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Ductal Carcinoma | Genetics | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Women